Delisting risk
Lucid Diagnostics
Commercializes EsoGuard testing on esophageal cells collected with EsoCheck.
$1.00
After-hours close+0.00 (+0.36%)
At close$0.9964(+1.26%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.04 | — | — |
| Aug 2026 | −$0.06 | −$0.06 | −5.9% |
| May 2026 | −$0.05 | −$0.07 | −40.0% |
| Mar 2026 | −$0.07 | −$0.10 | −42.9% |
| Nov 2025 | −$0.06 | −$0.10 | −66.7% |
The latest year is open to everyone — the 23 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Oct 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2018 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | −$0.04 | — | — | $1.6M | — | — |
| Aug 13, 2026 | −$0.06 | −$0.06 | −5.9% | $1.4M | $1.5M | +3.3% |
| May 14, 2026 | −$0.05 | −$0.07 | −40.0% | $1.4M | $1.3M | −9.0% |
| Mar 25, 2026 | −$0.07 | −$0.10 | −42.9% | $1.4M | $1.5M | +10.4% |
| Nov 12, 2025 | −$0.06 | −$0.10 | −66.7% | $1.4M | $1.2M | −12.7% |
The latest year is open to everyone — the 23 quarters behind it read with an account. Sign in | ||||||
| Aug 13, 2025 | ||||||
| May 14, 2025 | ||||||
| Mar 24, 2025 | ||||||
| Nov 13, 2024 | ||||||
| Aug 12, 2024 | ||||||
| May 13, 2024 | ||||||
| Mar 25, 2024 | ||||||
| Nov 13, 2023 | ||||||
| Aug 14, 2023 | ||||||
| May 15, 2023 | ||||||
| Mar 14, 2023 | ||||||
| Nov 14, 2022 | ||||||
| Aug 15, 2022 | ||||||
| May 11, 2022 | ||||||
| Mar 28, 2022 | ||||||
| Nov 23, 2021 | ||||||
| Oct 14, 2021 | ||||||
| Mar 31, 2021 | ||||||
| Dec 31, 2020 | ||||||
| Sep 30, 2020 | ||||||
| Jun 30, 2020 | ||||||
| Mar 31, 2020 | ||||||
| Dec 31, 2018 | ||||||